Location History:
- Nishinomiya, JP (2010)
- Okayama, JP (2007 - 2024)
Company Filing History:
4 out of 136 
2 out of 1,332 
2 out of 10 
Years Active: 2007-2024
Title: Junichiro Futami: Innovator in Cancer Research and Antibody Detection
Introduction
Junichiro Futami is a prominent inventor based in Okayama, Japan. He has made significant contributions to the fields of cancer research and antibody detection, holding a total of 7 patents. His work focuses on developing innovative solutions to combat cancer metastasis and improve diagnostic methods.
Latest Patents
Futami's latest patents include the "Anti-S100A8/A9 antibody and use thereof." This invention provides a substance capable of effectively suppressing cancer metastasis or a pharmaceutical composition that acts on inflammatory diseases. The composition contains an antibody or an antibody fragment that binds to the S100A8/A9 heterodimer, blocking its interaction with specific receptors. This action strongly suppresses cancer metastasis both in vitro and in vivo, or alleviates inflammation. Another notable patent is the "Method for producing reagent for antibody detection and use thereof." This invention outlines a method for efficiently producing a reagent that detects antibodies binding to insoluble antigen proteins in liquid samples. By using a cationizing agent, the method allows for the efficient solubilization and recovery of antigen proteins, improving the production of antibody detection reagents.
Career Highlights
Futami has worked with esteemed institutions such as Okayama University and Nippon Shokubai Co., Ltd. His experience in these organizations has contributed to his expertise in the development of innovative pharmaceutical compositions and diagnostic reagents.
Collaborations
Futami has collaborated with notable colleagues, including Hidenori Yamada and Hidetaka Nakanishi. Their joint efforts have further advanced the research and development of effective treatments and diagnostic tools.
Conclusion
Junichiro Futami's contributions to cancer research and antibody detection exemplify the impact of innovation in the medical field. His patents reflect a commitment to improving health outcomes through scientific advancement.